Clinical Trials Browser

Phase 2 × Bronchiolitis Obliterans Syndrome × ruxolitinib × Clear all

NCT03774082 2025-12-11

REACH 5

Phase 2 Completed

46 enrolled 21 charts

Bronchiolitis Obliterans Syndrome, Graft vs Host Disease, Lymphoma, Follicular

NCT05413356 2022-10-19

Ruxolitinib for Newly Diagnosed Bronchiolitis Obliterans Syndrome

Phase 2 Unknown

Other hematologic neoplasm

Bronchiolitis Obliterans Syndrome, Hematologic Neoplasms